1.0Leitat Technological Centerhttps://leitat.org/en/Dissemination Managerhttps://leitat.org/en/blog/author/editor-wp/rich600338<blockquote class="wp-embedded-content" data-secret="HuzrbDKMgs"><a href="https://leitat.org/en/blog/hpk1-inhib/">HPK1-INHIB</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://leitat.org/en/blog/hpk1-inhib/embed/#?secret=HuzrbDKMgs" width="600" height="338" title="“HPK1-INHIB” — Leitat Technological Center" data-secret="HuzrbDKMgs" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://leitat.org/wp-includes/js/wp-embed.min.js </script> https://leitat.org/wp-content/uploads/2026/01/HPK1-INHIB.png19201080Preclinical Discovery and Development of New Compounds as HPK1 Inhibitors for Cancer Treatment Abstract: The overall objective of the project is to discover and develop new HPK1 inhibitors at the preclinical level, with therapeutic potential in oncology. To achieve this, key stages will be addressed, including the design, synthesis, and optimization of compounds, evaluation of […]